APR 10, 2019 12:26 PM PDT

Possible Non-Antibiotic Strategy for Treating Bacterial Meningitis

WRITTEN BY: Nouran Amin

Due to the increasing threat of antibiotic resistance, there is a dire need for new strategies against life threatening bacterial infections. Now, scientists at Lund University in Sweden and the University of Copenhagen have identified an alternative treatment strategy for bacterial meningitis--a serious infection that can lead to sepsis. The study was published in Nature Communications.

"The development of resistance in bacteria is accelerating and we need alternatives to antibiotics. The drug we use in the studies is a therapeutic biological product derived from humans and has already been approved for human use. They are not expensive and have also been tested against many different bacteria and infections. Bacterial meningitis is a major challenge in many parts of the world. In India, for example, it is a major cause of death among children, so there would be significant benefits there from using such a treatment strategy," says Tirthankar Mohanty, one of the researchers behind the study.

Researchers studied the cerebrospinal fluid (CSF) of patients with bacterial meningitis via advanced microscopy. They were found to be cloudy and full of lumps, which indicated neutrophil extracellular traps (NETs). Interestingly, patients with viral meningitis had CSF that was free from NETs.

"It is as though in pure frustration they turn themselves inside out in a desperate attempt to capture the bacteria they have not been able to overcome. Using this approach, they capture a number of bacteria at once in net-like structures, or neutrophil extracellular traps (NETs). This works very well in many places in the body where the NETs containing the captured bacteria can be transported in the blood and then neutralized in the liver or spleen, for example. However, in the case of bacterial meningitis these NETs get caught in the cerebrospinal space, and the cleaning station there is not very effective," explains Adam Linder, associate professor at Lund University and specialist in Infectious Diseases at Skåne University Hospital.

The researchers were aware that NETS were mostly DNA and so they wondered what would happen if you brought in drugs used for cutting up DNA, so-called DNase.

"We gave DNase to rats infected with pneumococcus bacteria, which caused bacterial meningitis, and could show that the NETs dissolved and the bacteria disappeared. It seems that when we cut up the NETs, the bacteria are exposed to the immune system, which finds it easier to combat the bacteria single-handed. We were able to facilitate a significant reduction in the number of bacteria without antibiotic intervention, says Tirthankar Mohanty.

Researchers are now looking forward to setup DNase drugs for a major international clinical study for the treatment of patients with bacterial meningitis.

Source: ScienceDaily.com

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
JAN 16, 2020
Drug Discovery & Development
JAN 16, 2020
Fatty Acid Supplement Repairs Brain After Stroke in Mice
Researchers have found that supplements containing short chain fatty acids (SCFAs) may be able to help the brain recover from having a stroke. This comes a
FEB 03, 2020
Drug Discovery & Development
FEB 03, 2020
HIV Viral Structures Improve Therapeutics
Researchers have recently discovered how a powerful class of HIV drugs bind to a key piece of HIV machinery. Their findings, for the first time, shows how
FEB 28, 2020
Drug Discovery & Development
FEB 28, 2020
How Dietary Supplement Citicoline Improves Memory
For some time now, Citicoline has been known for its ability to improve memory and reduce cognitive decline. A primary ingredient in many pre-made nootropi
MAR 03, 2020
Drug Discovery & Development
MAR 03, 2020
Drug Used for Ebola Virus Could Fight COVID19
Previously, the drug remdesivir was found to treat coronaviruses that cause Middle East respiratory syndrome (MERS) and severe acute respiratory syndrome (
MAR 23, 2020
Cancer
MAR 23, 2020
An Alternative Use for Common Kidney Cancer Drug to Fight Against Epithelial Ovarian Cancer
Axitinib is a small molecule drug that inhibits VEGFR tyrosine kinases 1, 2, and 3. Shown previously to potentially prev...
APR 08, 2020
Drug Discovery & Development
APR 08, 2020
Does Tuberculosis Vaccine Really Defend from COVID-19?
The spread of COVID-19 has panned out very differently in different countries. While in some such as the US, the UK and Italy it has hit hard, in others, i
Loading Comments...